Bioactivity:

Protein Kinase C 19-31 acetate, a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase C substrate

CAS nr:

TP1053L

Purity:

98%

Molecular Weight:

1603,9

SMILES:

O=C(N[C@@H](C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(NCC(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCCN)C(N[C@@H](CC(N)=O)C(N[C@H](C(O)=O)C(C)C)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@@H](NC([C@@H](N)CCCNC(N)=N)=O)CC1=CC=CC=C1.CC(O)=O

Formula:

C69H122N26O18

Pathway:

Cytoskeletal Signaling,Chromatin/Epigenetic

Target:

PKC,PKC